Atlas Trials

Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression

Clinical trial NCT06898424 · COMPLETED

Trial details

NCT number
NCT06898424
Sponsor
Prof. Lutfu Hanoglu, MD
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Type DementiaAlzheimer's Disease (AD)
Start date
2024-03-01
Primary completion
2024-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.